Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.
äŒæ¥ã³ãŒãBDX
äŒç€ŸåBecton Dickinson and Co
äžå Žæ¥Oct 31, 2099
æé«çµå¶è²¬ä»»è
ãCEOãPolen (Thomas E)
åŸæ¥å¡æ°72000
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Oct 31
æ¬ç€Ÿæåšå°One Becton Drive
éœåžFRANKLIN LAKES
蚌åžååŒæNASDAQ OMX NASDAQ Basic NYSE
åœUnited States of America
éµäŸ¿çªå·07417-1880
é»è©±çªå·12018476800
ãŠã§ããµã€ãhttps://www.bd.com/
äŒæ¥ã³ãŒãBDX
äžå Žæ¥Oct 31, 2099
æé«çµå¶è²¬ä»»è
ãCEOãPolen (Thomas E)